Genpact Ltd. has been awarded a five-year contract extension by GlaxoSmithKline for finance and accounting (F&A) services. Genpact will continue to deliver global services including accounts payable, record-to-report, and order-to-cash across several global regions.
 
Paul Fry, senior vice president for Finance Services in GSK’s Core Business Services, said, “Our continued partnership with Genpact is a key element in our drive to deliver simpler, more efficient and standardized business processes for GSK.”
 
BK Kalra, senior vice president and business leader, Life Sciences, Genpact, remarked, “Over the last six years, the partnership between Genpact and GSK has been able to address GSK’s growing global business and the unique challenges within the pharmaceutical market while improving the outcomes of these end-to-end processes, especially through our Lean and Six Sigma framework. We are thrilled to expand our valued relationship with GSK and ensure continuous process effectiveness so that their path to future growth is smooth.”